FOLH1 and prostate carcinoma: Supporting this perspective, a recent review summarized the anticancer properties of melittin and other bee venom components in prostate cancer models, highlighting a range of explored targets, such as MMP-2, PSMA, fibroblast activation protein, and hormone receptors [85].